These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8674061)

  • 1. Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer.
    Hamada K; Alemany R; Zhang WW; Hittelman WN; Lotan R; Roth JA; Mitchell MF
    Cancer Res; 1996 Jul; 56(13):3047-54. PubMed ID: 8674061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adenovirus-mediated p53 gene therapy of human laryngeal cancer].
    Wang Q; Han D; Wang W
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):418-21. PubMed ID: 10920932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer.
    Hamada K; Shirakawa T; Gotoh A; Roth JA; Follen M
    Gynecol Oncol; 2006 Dec; 103(3):820-30. PubMed ID: 16908054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck.
    Liu TJ; el-Naggar AK; McDonnell TJ; Steck KD; Wang M; Taylor DL; Clayman GL
    Cancer Res; 1995 Jul; 55(14):3117-22. PubMed ID: 7606733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells.
    Hamada K; Sakaue M; Alemany R; Zhang WW; Horio Y; Roth JA; Mitchell MF
    Gynecol Oncol; 1996 Nov; 63(2):219-27. PubMed ID: 8910631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus.
    Zhang WW; Fang X; Mazur W; French BA; Georges RN; Roth JA
    Cancer Gene Ther; 1994 Mar; 1(1):5-13. PubMed ID: 7621238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibition of human cervical cancer cells with the recombinant adenovirus p53 in vitro.
    Hamada K; Zhang WW; Alemany R; Wolf J; Roth JA; Mitchell MF
    Gynecol Oncol; 1996 Mar; 60(3):373-9. PubMed ID: 8774641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus.
    Liu TJ; Zhang WW; Taylor DL; Roth JA; Goepfert H; Clayman GL
    Cancer Res; 1994 Jul; 54(14):3662-7. PubMed ID: 8033080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo.
    Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW
    Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nude rat as an orthotopic model for cervical cancer.
    Hamada K; Ueda N; Ito M; Roth JA; Follen M
    Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S159-65. PubMed ID: 16185752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines.
    Parker LP; Wolf JK; Price JE
    Ann Clin Lab Sci; 2000 Oct; 30(4):395-405. PubMed ID: 11045764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preclinical model of minimal residual cancer in the muscle highlights challenges associated with adenovirus-mediated p53 gene transfer.
    Oakley R; Phillips E; Hooper R; Wilson D; Partridge M
    Clin Cancer Res; 2002 Jun; 8(6):1984-94. PubMed ID: 12060644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic effects of Ad5CMV-p53 expression in two human nasopharyngeal carcinoma cell lines.
    Li JH; Li P; Klamut H; Liu FF
    Clin Cancer Res; 1997 Apr; 3(4):507-14. PubMed ID: 9815713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.
    Harris MP; Sutjipto S; Wills KN; Hancock W; Cornell D; Johnson DE; Gregory RJ; Shepard HM; Maneval DC
    Cancer Gene Ther; 1996; 3(2):121-30. PubMed ID: 8729911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts.
    Nielsen LL; Dell J; Maxwell E; Armstrong L; Maneval D; Catino JJ
    Cancer Gene Ther; 1997; 4(2):129-38. PubMed ID: 9080122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
    Komata T; Kondo Y; Koga S; Ko SC; Chung LW; Kondo S
    Gene Ther; 2000 Dec; 7(24):2071-9. PubMed ID: 11223987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer.
    Spitz FR; Nguyen D; Skibber JM; Cusack J; Roth JA; Cristiano RJ
    Anticancer Res; 1996; 16(6B):3415-22. PubMed ID: 9042200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma.
    Clayman GL; el-Naggar AK; Roth JA; Zhang WW; Goepfert H; Taylor DL; Liu TJ
    Cancer Res; 1995 Jan; 55(1):1-6. PubMed ID: 7805018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo gene therapy with p53 or p21 adenovirus for prostate cancer.
    Eastham JA; Hall SJ; Sehgal I; Wang J; Timme TL; Yang G; Connell-Crowley L; Elledge SJ; Zhang WW; Harper JW
    Cancer Res; 1995 Nov; 55(22):5151-5. PubMed ID: 7585563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bax-induced apoptosis as a novel gene therapy approach for carcinoma of the cervix.
    Huh WK; Gomez-Navarro J; Arafat WO; Xiang J; Mahasreshti PJ; Alvarez RD; Barnes MN; Curiel DT
    Gynecol Oncol; 2001 Nov; 83(2):370-7. PubMed ID: 11606099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.